Clin2
NCT07566806Possibly a fitRecruiting

Cord Plasma Eye Drops for Nerve Pain in the Eye

Neuropathic PainCorneal Disease

Part of Brain & nervous system, Eyes & vision, Pain clinical trials.

This trial tests whether special eye drops made from cord plasma (a blood product) can reduce chronic eye pain caused by damaged nerves in the cornea (the clear front part of your eye). You may qualify if you have had eye pain for at least 3 months without obvious surface damage.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • Persistent eye pain for at least 3 months with symptoms like burning, stinging, or sharp sensations
  • Confirmed nerve damage in the cornea visible on specialized imaging (confocal microscopy)
  • Little to no visible surface damage on standard eye exams
  • Willingness to receive cord plasma eye drops as treatment
  • No active eye infections, blepharitis (eyelid inflammation), or other inflammatory eye diseases
  • Not currently using steroid drops, immunosuppressant medications, or oral pain relievers that could interfere with results

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07174739Recruiting
Testing a new treatment for nerve pain in the eye

This study tests a new non-invasive treatment (Quantum Molecular Resonance) to see if it can reduce pain and help damaged nerves in the eye heal. It may help people with long-lasting eye pain caused by nerve damage.

Singapore
NCT07849803Not yet recruiting· Phase 4
Eye drops for dry eyes and nerve pain

This trial tests a new eye drop (acoltre mon) to see if it helps people who have both dry eyes and nerve-related eye pain. The drops may increase tear production and reduce burning or light sensitivity.

Tampa, Florida
NCT07838506Not yet recruiting· Phase 3
Eye drops for nerve-related eye pain

This study tests an investigational eye drop called urcosimod to see if it can reduce pain from a condition called neuropathic corneal pain, which happens when the nerves in the clear front part of your eye are damaged. If you join, you would use the eye drops for a period and report your pain levels.

Nashville, Tennessee
NCT06975748Recruiting· Phase 2
Eye Drop for Nerve-Damaged Corneas

This trial tests an experimental eye drop (STSP-0902) for a condition called neurotrophic keratitis, where the cornea (the clear front part of the eye) gets scratches or sores because nerves are damaged. The drop contains a growth factor to help the eye heal. You might be eligible if you have a persistent scratch or sore on your cornea that has not improved for at least a week.

Jinan, Shandong
NCT04604834Recruiting
Platelet-rich plasma treatment for corneal nerve damage

This trial studies whether your own platelet-rich plasma can help heal a fragile, slow-to-recover cornea caused by reduced corneal feeling (nerve damage). It may help reduce corneal erosion and improve corneal surface healing.

Monterrey, Nuevo León
NCT07073729Not yet recruiting
Nerve surgery or eye drops for neurotrophic keratitis

This study compares two treatments for neurotrophic keratitis, a condition where the cornea (the clear front part of the eye) loses feeling due to nerve damage. One treatment is a surgery that restores nerves to the cornea, and the other is a special eye drop that helps the cornea heal. The goal is to see which treatment works better for improving eye health and vision.

London, Ontario

Hear when a new Neuropathic Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.